Buprenorphine Neuraxpharm
Active substance: buprenorphine
buprenorphine hydrochloride
Centralised EU authorisationActive
Marketing holder: Neuraxpharm Pharmaceuticals S.L.
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 7 |
|
| US 208 |
|
Control by country
- RussiacontrolledSchedule: НII
Source: GRLS (Russian state register) · record 01a120c3-bd21-779a-8080-6ca8ba1e1dd6,01a120c4-0ac0-7b77-a5a5-7bda73aafb1e,01a120c4-5289-72d6-ac10-0353dbb548f4,01a120c4-dbbf-7300-84d2-04741bd77a69,01a120c6-c5f6-7c33-96c3-6d44372e4478;count=5 · valid from 2026-10-09 · verified 2026-10-09
- United StatescontrolledSchedule: CIII
Source: openFDA NDC · record 01a1208c-2937-73ab-aef4-01b9d38f8c93,01a1208c-29e0-79a9-a91f-9801dd89ca92,01a1208c-2d79-78ff-9916-89a22866e6dd,01a1208c-2e6f-7ce5-9efd-3fd3a973bd46,01a1208c-5bca-7845-9f7c-1bb5838e5eb6;count=106 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- EMEA/H/C/006188
- Registration status
- Active
- ATC code
- N07BC01
- product · EMA · EMEA/H/C/006188 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/006188 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/006188 · Verified 2026-10-09